Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Industrials | 8.98% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Karyopharm Therapeutics
KPTI
$43.3M
| $813K | ﹤0.01% |
80,173
-2,587
| -3% | -$31.3K |
|
2602
Prelude Therapeutics
PRLD
$362M
| $809K | ﹤0.01% |
634,500
+437,600
| +222% | +$581K |
|
2603
Red River Bancshares
RRBI
$665M
| $804K | ﹤0.01% |
14,900
+1,400
| +10% | +$77.5K |
|
|
CMPS
2604
Compass Pathways
CMPS
$1.83B
| $804K | ﹤0.01% |
212,700
+131,300
| +161% | +$666K |
|
2605
iShares MSCI Canada ETF
EWC
$6.27B
| $802K | ﹤0.01% |
19,900
-25,700
| -56% | -$1.07M |
|
2606
Aveanna Healthcare
AVAH
$2.03B
| $801K | ﹤0.01% |
175,300
-118,400
| -40% | -$606K |
|
2607
Hawthorn Bancshares
HWBK
$274M
| $801K | ﹤0.01% |
28,243
+3,000
| +12% | +$84.1K |
|
2608
AN2 Therapeutics
ANTX
$210M
| $800K | ﹤0.01% |
579,773
+155,973
| +37% | +$189K |
|
2609
iShares US Transportation ETF
IYT
$2.28B
| $797K | ﹤0.01% |
+11,800
| New | +$834K |
|
2610
AMES National
ATLO
$277M
| $797K | ﹤0.01% |
48,484
-800
| -2% | -$13.8K |
|
2611
Hooker Furnishings Corp
HOFT
$159M
| $796K | ﹤0.01% |
56,800
-3,500
| -6% | -$58.9K |
|
2612
Voyager Therapeutics
VYGR
$187M
| $793K | ﹤0.01% |
139,900
-138,767
| -50% | -$895K |
|
2613
AudioEye
AEYE
$74.2M
| $792K | ﹤0.01% |
52,100
+12,700
| +32% | +$290K |
|
2614
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
| $789K | ﹤0.01% |
31,700
-3,300
| -9% | -$82.9K |
|
2615
Hamilton Beach Brands
HBB
$323M
| $789K | ﹤0.01% |
46,900
+5,628
| +14% | +$130K |
|
|
MNTX
2616
DELISTED
Manitex International, Inc.
MNTX
| $787K | ﹤0.01% |
135,740
-41,700
| -24% | -$238K |
|
2617
Invesco
IVZ
$14.1B
| $787K | ﹤0.01% |
45,000
-509,300
| -92% | -$9.07M |
|
2618
iShares Global 100 ETF
IOO
$9.18B
| $786K | ﹤0.01% |
+7,800
| New | +$783K |
|
2619
Passage Bio
PASG
$14.8M
| $783K | ﹤0.01% |
69,074
-568
| -0.8% | -$7.4K |
|
|
ELP
2620
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $782K | ﹤0.01% |
131,900
+66,200
| +101% | +$438K |
|
2621
Outdoor Holding Co
POWW
$252M
| $782K | ﹤0.01% |
710,700
+32,700
| +5% | +$38.9K |
|
2622
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $781K | ﹤0.01% |
39,400
-69,300
| -64% | -$1.43M |
|
|
ITRM
2623
DELISTED
Iterum Therapeutics
ITRM
| $777K | ﹤0.01% |
+438,816
| New | +$688K |
|
2624
Avantis Emerging Markets Equity ETF
AVEM
$26.2B
| $776K | ﹤0.01% |
+13,200
| New | +$822K |
|
2625
Constellium
CSTM
$4.02B
| $775K | ﹤0.01% |
+75,500
| New | +$929K |
|
Similar funds
Renaissance Technologies's Q4 2024 Portfolio in Review
As of Q4 2024, Renaissance Technologies held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Renaissance Technologies added most to Alibaba in Q4 2024, an estimated $191M increase.
- Renaissance Technologies's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Renaissance Technologies fully exited Arm in Q4 2024, selling an estimated $153M.
- Renaissance Technologies's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Renaissance Technologies opened 548 new positions and closed 497 in Q4 2024.
- Renaissance Technologies's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.